High serum adiponectin has been proposed by some authors as a predictor of progression to ESRD in CKD patients; however, some data suggest that adiponectin may be a biomarker of renal dysfunction, instead of a risk factor of CKD progression [20]. This evidence concerns the gene ADIPOQ and chronic kidney disease.